SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ATAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 71.80M
March 31, 2026 68.93M
December 31, 2025 65.09M
September 30, 2025 50.27M
June 30, 2025 49.16M
March 31, 2025 46.81M
September 30, 2024 55.64M
June 30, 2024 59.01M
March 31, 2024 62.17M
December 31, 2023 63.58M
September 30, 2023 59.89M
June 30, 2023 65.67M
March 31, 2023 66.34M
Date Value
December 31, 2022 70.35M
September 30, 2022 80.50M
June 30, 2022 81.34M
March 31, 2022 101.45M
December 31, 2021 92.74M
September 30, 2021 66.87M
June 30, 2021 50.93M
March 31, 2021 16.45M
December 31, 2020 8.749M
September 30, 2020 8.749M
June 30, 2020 4.421M
March 31, 2020 1.57M
December 31, 2019 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 12.24B
GH Research Plc 24.75M
Johnson & Johnson 25.14B
Merck & Co., Inc. 11.14B
Zoetis, Inc. 2.378B